Sridhar VS, Kugathasan L, Lytvyn Y, Deng Y, et al. Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial. Hypertension 2025 Dec 5. doi: 10.1161/HYPERTENSIONAHA.125.25955.
PMID: 41347301